Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_provenance.
- NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_assertion description "[Targeting PLK1 in OS with NMS-P937 in association with conventional chemotherapeutic drugs may be a new interesting therapeutic option, since this approach has proved to be active against drug resistant cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_provenance.
- NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_assertion evidence source_evidence_literature NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_provenance.
- NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_assertion SIO_000772 25193492 NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_provenance.
- NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_assertion wasDerivedFrom befree-2016 NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_provenance.
- NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_assertion wasGeneratedBy ECO_0000203 NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_provenance.
- befree-2016 importedOn "2016-02-19" NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_provenance.